Skip to main content

Table 2 Changes in the basal serum luteinizing hormone (LH), follicle-stimulating hormone (FSH) and testosterone (TE) levels from baseline to one course of treatment

From: Benefits from the first year of GnRHa therapy in boys with idiopathic central precocious puberty when initiating treatment after age 9 years: findings from a real-world retrospective study

Time point, month

LH, IU/L

FSH, IU/L

TE, nmol/L

0

2.09 ± 0.85

3.75 ± 1.18

5.19 ± 4.41

3

2.80 ± 1.64

0.98 ± 0.65

0.16 ± 0.10

P value

> 0.05

< 0.05

< 0.05

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us